EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre

Antonio De Leo iD, Daniela Serban iD, Thais Maloberti iD, Viviana Sanza, Sara Coluccelli iD, Annalisa Altimari, Elisa Gruppioni, Federico Chiarucci iD, Angelo Gianluca Corradini, Andrea Repaci, Alessandra Colapinto iD, Margherita Nannini iD und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24044057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Antonio De Leo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Adenocarcinoma, Follicular, Proto-Oncogene Proteins B-raf, Thyroid Neoplasms, Thyroid Nodule. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The BRAF p.V600E mutation represents the most specific marker for papillary thyroid carcinoma and is potentially related to aggressive behavior and persistent disease. BRAF alterations other than the p.V600E are less common in thyroid carcinoma and represent an alternative mechanism of BRAF activation with unclear clinical significance. The study aims to describe the frequency and clinicopathologic characteristics of BRAF non-V600E mutations in a large cohort (1654 samples) of thyroid lesions characterized by next-generation sequencing. BRAF mutations have been found in 20.3% (337/1654) of thyroid nodules, including classic (p.V600E) mutation in 19.2% (317/1654) of samples and non-V600E variants in 1.1% of cases (19/1654). BRAF non-V600E alterations include 5 cases harboring p.K601E, 2 harboring p.V600K substitutions, 2 with a p.K601G variant, and 10 cases with other BRAF non-V600E alterations. BRAF non-V600E mutations have been reported in one case of follicular adenoma, three cases of conventional papillary thyroid carcinoma, eight cases of follicular variant of papillary carcinomas, one case of columnar cell variant papillary thyroid carcinoma, one case of oncocytic follicular carcinoma, and two bone metastasis of follicular thyroid carcinoma. We confirm that BRAF non-V600E mutations are uncommon and typically found in indolent follicular-patterned tumors. Indeed, we show that BRAF non-V600E mutations can be found in tumors with metastatic potential. However, in both aggressive cases, the BRAF mutations were concomitant with other molecular alterations, such as TERT promoter mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma, FollicularProto-Oncogene Proteins B-rafThyroid NeoplasmsThyroid NoduleHumansDNA Mutational AnalysisMutationTertiary Care CentersThyroid Cancer, Papillary

Stichwörter der Autor:innen

BRAFmutationnext-generation sequencingnoncanonical mutationthyroid tumors

Substanzen

BRAF protein, humanProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.
  • Anatomic Pathology, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.
  • Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Antonio De Leo, Daniela Serban, Thais Maloberti, Sara Coluccelli, Federico Chiarucci, Alessandra Colapinto, Margherita Nannini, Dario de Biase, Giovanni Tallini

Förderung

  • Italian Ministry of Health

Zitieren

APA

De Leo, A., Serban, D., Maloberti, T., Sanza, V., Coluccelli, S., Altimari, A., Gruppioni, E., Chiarucci, F., Corradini, A. G., Repaci, A., Colapinto, A., Nannini, M., Pantaleo, M. A., de Biase, D., & Tallini, G. (2023). Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044057

Vancouver

De Leo A, Serban D, Maloberti T, Sanza V, Coluccelli S, Altimari A, et al. Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044057

BibTeX
@article{DeLeo2023,
  author = {De Leo, Antonio and Serban, Daniela and Maloberti, Thais and Sanza, Viviana and Coluccelli, Sara and Altimari, Annalisa and Gruppioni, Elisa and Chiarucci, Federico and Corradini, Angelo Gianluca and Repaci, Andrea and Colapinto, Alessandra and Nannini, Margherita and Pantaleo, Maria A and de Biase, Dario and Tallini, Giovanni},
  title = {Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24044057}
}
Kostenlos starten →